Foundayo (Orforglipron) : This flexible oral GLP-1 option allows for dosing without meal-time restrictions
Polygonatum sibiricum polysaccharide inhibits high glucose-induced oxidative stress, inflammatory response, and apoptosis in RPE cells
Retatrutide, an investigational triple GIP/GLP-1/glucagon receptor agonist developed by Eli Lilly, demonstrated unprecedented weight loss in Phase 2 trials but has not yet completed Phase 3 development
Fortunately, medical providers and scientifically proven treatments can assist in shedding those stubborn pounds
MT-1 (Melanotan I) acts as a non-selective melanocortin receptor agonist and stimulates pigmentation primarily through MC1R activation in melanocytes, which regulates melanin synthesis and increases eumelanin production
The 0.5ml syringe (50-unit capacity) is the most versatile option for a 5mg/ml protocol